Goldenberg RM, Cheng AYY, Fitzpatrick T, Gilbert JD, et al. Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists. Stroke 2022 Mar 9:STROKEAHA121038151. doi: 10.1161/STROKEAHA.121.038151.
PMID: 35259929